Why are we Interested in the Unfolded Peptides and Proteins?

Protein and Peptide Folding, Misfolding, and Non-Folding

Volumn , Issue , 2012, Pages 1-54

  Uversky, Vladimir N ^a   Dunker, A Keith ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Disordered proteins, heterogeneous; Natively unfolded proteins, drug targets; Unfolded peptides and proteins

Indexed keywords

EID: 84888740263     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118183373.ch1     Document Type: Chapter

References (237)

1. Dunker, A. K., Garner, E., Guilliot, S., Romero, P., Albrecht, K., Hart, J., Obradovic, Z., Kissinger, C., and Villafranca, J. E. (1998) Protein disorder and the evolution of molecular recognition: Theory, predictions and observations, Pac Symp Biocomput, 473-484.
2. Wright, P. E. and Dyson, H. J. (1999) Intrinsically unstructured proteins: Re - assessing the protein structure - function paradigm, J Mol Biol 293, 321-331.
3. Uversky, V. N., Gillespie, J. R., and Fink, A. L. (2000) Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins 41, 415-427.
4. Dunker, A. K., Lawson, J. D., Brown, C. J., Williams, R. M., Romero, P., Oh, J. S., Oldfield, C. J., Campen, A. M., Ratliff, C. M., Hipps, K. W., Ausio, J., Nissen, M. S., Reeves, R., Kang, C., Kissinger, C. R., Bailey, R. W., Griswold, M. D., Chiu, W., Garner, E. C., and Obradovic, Z. (2001) Intrinsically disordered protein, J Mol Graph Model 19, 26-59.
5. Tompa, P. (2002) Intrinsically unstructured proteins, Trends Biochem Sci 27, 527-533.
6. Daughdrill, G. W., Pielak, G. J., Uversky, V. N., Cortese, M. S., and Dunker, A. K. (2005) Natively disordered proteins. In: Buchner, J. and Kiefhaber, T. (eds.), Handbook of protein folding. Wiley - VCH, Verlag GmbH & Co. KGaA, Weinheim, Germany, pp. 271-353.
7. Uversky, V. N. and Dunker, A. K. (2010) Understanding protein non - folding, Biochim Biophys Acta 1804, 1231-1264.
8. Holt, C. and Sawyer, L. (1993) Caseins as rheomorphic proteins: Interpretation of primary and secondary structures of the as1 -, b -, and k - caseins, J Chem Soc Faraday Trans 89, 2683-2692.
9. Pullen, R. A., Jenkins, J. A., Tickle, I. J., Wood, S. P., and Blundell, T. L. (1975) The relation of polypeptide hormone structure and flexibility to receptor binding: The relevance of X - ray studies on insulins, glucagon and human placental lactogen, Mol Cell Biochem 8, 5-20.
10. Cary, P. D., Moss, T., and Bradbury, E. M. (1978) High - resolution proton - magnetic -resonance studies of chromatin core particles, Eur J Biochem 89, 475-482.
11. Linderstrom - Lang, K. and Schellman, J. A. (1959) Protein structure and enzyme activity. In: Boyer, P. D., Lardy, H., and Myrback, K. (eds.), The enzymes, 2nd ed., Academic Press, New York, pp. 443-510.
12. Schweers, O., Schonbrunn - Hanebeck, E., Marx, A., and Mandelkow, E. (1994) Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta - structure, J Biol Chem 269, 24290-24297.
13. Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A., and Lansbury, P. T., Jr (1996) NACP, a protein implicated in Alzheimer ' s disease and learning, is natively unfolded, Biochemistry 35, 13709-13715.
14. Chen, J., Liang, H., and Fernandez, A. (2008) Protein structure protection commits gene expression patterns, Genome Biol 9, R107.
15. Uversky, V. N. (2003) A protein - chameleon: Conformational plasticity of alpha -synuclein, a disordered protein involved in neurodegenerative disorders, J Biomol Struct Dyn 21, 211-234.
16. Fuxreiter, M., Tompa, P., Simon, I., Uversky, V. N., Hansen, J. C., and Asturias, F. J. (2008) Malleable machines take shape in eukaryotic transcriptional regulation, Nat Chem Biol 4, 728-737.
17. Tsvetkov, P., Asher, G., Paz, A., Reuven, N., Sussman, J. L., Silman, I., and Shaul, Y. (2008) Operational definition of intrinsically unstructured protein sequences based on susceptibility to the 20S proteasome, Proteins 70, 1357-1366.
18. Dunker, A. K. and Uversky V. N. (2010) Drugs for "protein clouds": targeting intrinsically disordered transcription factors, Curr Opin Pharmacol 10 (6), 782-788.
19. Livesay, D. R. (2010) Protein dynamics: Dancing on an ever - changing free energy stage, Curr Opin Pharmacol 10, 706-708.
20. Uversky, V. N. (2010) The mysterious unfoldome: Structureless, underappreciated, yet vital part of any given proteome, J Biomed Biotechnol 2010, 568068.
21. Dunker, A. K. and Obradovic, Z. (2001) The protein trinity - Linking function and disorder, Nat Biotechnol 19, 805-806.
22. Uversky, V. N. (2002) Natively unfolded proteins: A point where biology waits for physics, P rotein Sci 11, 739-756.
23. Iakoucheva, L. M., Brown, C. J., Lawson, J. D., Obradovic, Z., and Dunker, A. K. (2002) Intrinsic disorder in cell - signaling and cancer - associated proteins, J Mol Biol 323, 573-584.
24. Dunker, A. K., Cortese, M. S., Romero, P., Iakoucheva, L. M., and Uversky, V. N. (2005) Flexible nets: The roles of intrinsic disorder in protein interaction networks, FEBS J 272, 5129-5148.
25. Uversky, V. N., Oldfield, C. J., and Dunker, A. K. (2005) Showing your ID: Intrinsic disorder as an ID for recognition, regulation and cell signaling, J Mol Recognit 18, 343-384.
26. Radivojac, P., Iakoucheva, L. M., Oldfield, C. J., Obradovic, Z., Uversky, V. N., and Dunker, A. K. (2007) Intrinsic disorder and functional proteomics, Biophys J 92, 1439-1456.
27. Halle, B. (2002) Flexibility and packing in proteins, Proc Natl Acad Sci U S A 99, 1274-1279.
28. Sickmeier, M., Hamilton, J. A., LeGall, T., Vacic, V., Cortese, M. S., Tantos, A., Szabo, B., Tompa, P., Chen, J., Uversky, V. N., Obradovic, Z., and Dunker, A. K. (2007) DisProt: The database of disordered proteins, Nucleic Acids Res 35, D786-D793.
29. Dunker, A. K., Oldfield, C. J., Meng, J., Romero, P., Yang, J. Y., Chen, J. W., Vacic, V., Obradovic, Z., and Uversky, V. N. (2008) The unfoldomics decade: An update on intrinsically disordered proteins, BMC Genomics 9, Suppl 2, S1.
30. Uversky, V. N. (2009) Intrinsic disorder in proteins associated with neurodegenerative diseases, Front Biosci 14, 5188-5238.
31. Uversky, V. N. (2008) Alpha - synuclein misfolding and neurodegenerative diseases, Curr Protein Pept Sci 9, 507-540.
32. Receveur - Brechot, V., Bourhis, J. M., Uversky, V. N., Canard, B., and Longhi, S. (2006) Assessing protein disorder and induced folding, Proteins 62, 24-45.
33. Hemmings, H. C., Jr, Nairn, A. C., Aswad, D. W., and Greengard, P. (1984) DARPP - 32, a dopamine - and adenosine 3 ':5 ' - monophosphate - regulated phosphoprotein enriched in dopamine - innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus, J Neurosci 4, 99-110.
34. Gast, K., Damaschun, H., Eckert, K., Schulze - Forster, K., Maurer, H. R., Muller -Frohne, M., Zirwer, D., Czarnecki, J., and Damaschun, G. (1995) Prothymosin alpha: A biologically active protein with random coil conformation, Biochemistry 34, 13211-13218.
35. Garner, E., Cannon, P., Romero, P., Obradovic, Z., and Dunker, A. K. (1998) Predicting disordered regions from amino acid sequence: Common themes despite differing structural characterization, Genome Inform Ser Workshop Genome Inform 9, 201-213.
36. Williams, R. M., Obradovi, Z., Mathura, V., Braun, W., Garner, E. C., Young, J., Takayama, S., Brown, C. J., and Dunker, A. K. (2001) The protein non - folding problem: Amino acid determinants of intrinsic order and disorder, Pac Symp Biocomput, 89-100.
37. Romero, P., Obradovic, Z., Li, X., Garner, E. C., Brown, C. J., and Dunker, A. K. (2001) Sequence complexity of disordered protein, Proteins 42, 38-48.
38. Vacic, V., Uversky, V. N., Dunker, A. K., and Lonardi, S. (2007) Composition profiler: A tool for discovery and visualization of amino acid composition differences, BMC Bioinformatics 8, 211.
39. Li, X., Obradovic, Z., Brown, C. J., Garner, E. C., and Dunker, A. K. (2000) Comparing predictors of disordered protein, Genome Inform Ser Workshop Genome Inform 11, 172-184.
40. Campen, A., Williams, R. M., Brown, C. J., Meng, J., Uversky, V. N., and Dunker, A. K. (2008) TOP - IDP - scale: A new amino acid scale measuring propensity for intrinsic disorder, Protein Pept Lett 15, 956-963.
41. He, B., Wang, K., Liu, Y., Xue, B., Uversky, V. N., and Dunker, A. K. (2009) Predicting intrinsic disorder in proteins: An overview, Cell Res 19, 929-949.
42. Romero, P., Obradovic, Z., Kissinger, C. R., Villafranca, J. E., Garner, E., Guilliot, S., and Dunker, A. K. (1998) Thousands of proteins likely to have long disordered regions, Pac Symp Biocomput, 437-448.
43. Dunker, A. K., Obradovic, Z., Romero, P., Garner, E. C., and Brown, C. J. (2000) Intrinsic protein disorder in complete genomes, Genome Inform Ser Workshop Genome Inform 11, 161-171.
44. Le Gall, T., Romero, P. R., Cortese, M. S., Uversky, V. N., and Dunker, A. K. (2007) Intrinsic disorder in the Protein Data Bank, J Biomol Struct Dyn 24, 325-342.
45. Uversky, V. N. and Ptitsyn, O. B. (1994) "Partly folded" state, a new equilibrium state of protein molecules: Four - state guanidinium chloride - induced unfolding of beta -lactamase at low temperature, Biochemistry 33, 2782-2791.
46. Uversky, V. N. and Ptitsyn, O. B. (1996) Further evidence on the equilibrium "pre -molten globule state ": Four - state guanidinium chloride - induced unfolding of carbonic anhydrase B at low temperature, J Mol Biol 255, 215-228.
47. Ptitsyn, O. B. (1995) Molten globule and protein folding, Adv Protein Chem 47, 83-229.
48. Uversky, V. N. (2003) Protein folding revisited. A polypeptide chain at the foldingmisfolding-nonfolding cross- roads: Which way to go? Cell Mol Life Sci 60, 1852-1871.
49. Tcherkasskaya, O. and Uversky, V. N. (2001) Denatured collapsed states in protein folding: Example of apomyoglobin, Proteins 44, 244-254.
50. Ptitsyn, O. B. (1994) Kinetic and equilibrium intermediates in protein folding, Protein Eng 7, 593-596.
51. Tanford, C. (1968) Protein denaturation, Adv Protein Chem 23, 121-282.
52. Uversky, V. N. (1993) Use of fast protein size - exclusion liquid chromatography to study the unfolding of proteins which denature through the molten globule, Biochemistry 32, 13288-13298.
53. Uversky, V. N. (2002) What does it mean to be natively unfolded? Eur J Biochem 269, 2-12.
54. Glatter, O. and Kratky, O. (1982) Small angle X - ray scattering, Academic Press, London.
55. Semisotnov, G. V., Kihara, H., Kotova, N. V., Kimura, K., Amemiya, Y., Wakabayashi, K., Serdyuk, I. N., Timchenko, A. A., Chiba, K., Nikaido, K., Ikura, T., and Kuwajima, K. (1996) Protein globularization during folding. A study by synchrotron small - angle X - ray scattering, J Mol Biol 262, 559-574.
56. Uversky, V. N., Li, J., and Fink, A. L. (2001) Evidence for a partially folded intermediate in alpha - synuclein fibril formation, J Biol Chem 276, 10737-10744.
57. Uversky, V. N., Li, J., Souillac, P., Millett, I. S., Doniach, S., Jakes, R., Goedert, M., and Fink, A. L. (2002) Biophysical properties of the synucleins and their propensities to fibrillate: Inhibition of alpha - synuclein assembly by beta - and gamma - synucleins, J Biol Chem 277, 11970-11978.
58. Bhattacharyya, J. and Das, K. P. (1999) Molecular chaperone - like properties of an unfolded protein, alpha(s) - casein, J Biol Chem 274, 15505-15509.
59. Thomas, J., Van Patten, S. M., Howard, P., Day, K. H., Mitchell, R. D., Sosnick, T., Trewhella, J., Walsh, D. A., and Maurer, R. A. (1991) Expression in Escherichia coli and characterization of the heat - stable inhibitor of the cAMP - dependent protein kinase, J Biol Chem 266, 10906-10911.
60. Denning, D. P., Uversky, V., Patel, S. S., Fink, A. L., and Rexach, M. (2002) The Saccharomyces cerevisiae nucleoporin Nup2p is a natively unfolded protein, J Biol Chem 277, 33447-33455.
61. Denning, D. P., Patel, S. S., Uversky, V., Fink, A. L., and Rexach, M. (2003) Disorder in the nuclear pore complex: The FG repeat regions of nucleoporins are natively unfolded, P roc Natl Acad Sci U S A 100, 2450-2455.
62. Dyson, H. J. and Wright, P. E. (2001) Nuclear magnetic resonance methods for elucidation of structure and dynamics in disordered states, Methods Enzymol 339, 258-270.
63. Dyson, H. J. and Wright, P. E. (2002) Insights into the structure and dynamics of unfolded proteins from nuclear magnetic resonance, Adv Protein Chem 62, 311-340.
64. Dyson, H. J. and Wright, P. E. (2004) Unfolded proteins and protein folding studied by NMR, C hem Rev 104, 3607-3622.
65. Eliezer, D. (2007) Characterizing residual structure in disordered protein States using nuclear magnetic resonance, Methods Mol Biol 350, 49-67.
66. Eliezer, D. (2009) Biophysical characterization of intrinsically disordered proteins, Curr Opin Struct Biol 19, 23-30.
67. Muller - Spath, S., Soranno, A., Hirschfeld, V., Hofmann, H., Ruegger, S., Reymond, L., Nettels, D., and Schuler, B. (2010) From the Cover: Charge interactions can dominate the dimensions of intrinsically disordered proteins, Proc Natl Acad Sci U S A 107, 14609-14614.
68. Yamada, J., Phillips, J. L., Patel, S., Goldfien, G., Calestagne - Morelli, A., Huang, H., Reza, R., Acheson, J., Krishnan, V. V., Newsam, S., Gopinathan, A., Lau, E. Y., Colvin, M. E., Uversky, V. N., and Rexach, M. F. (2010) A bimodal distribution of two distinct categories of intrinsically disordered structures with separate functions in FG nucleoporins, M ol Cell Proteomics 9, 2205-2224.
69. Lau, K. F. and Dill, K. A. (1990) Theory for protein mutability and biogenesis, Proc Natl Acad Sci U S A 87, 638-642.
70. Ptitsyn, O. (1995) Molten globule and protein folding, Adv Protein Chem 47, 83-229.
71. Tcherkasskaya, O. and Uversky, V. N. (2003) Polymeric aspects of protein folding: A brief overview, Protein Pept Lett 10, 239-245.
72. Vitalis, A. and Pappu, R. V. (2009) ABSINTH: A new continuum solvation model for simulations of polypeptides in aqueous solutions, J Comput Chem 30, 673-699.
73. Vitalis, A., Wang, X., and Pappu, R. V. (2007) Quantitative characterization of intrinsic disorder in polyglutamine: Insights from analysis based on polymer theories, Biophys J 93, 1923-1937.
74. Vitalis, A., Wang, X., and Pappu, R. V. (2008) Atomistic simulations of the effects of polyglutamine chain length and solvent quality on conformational equilibria and spontaneous homodimerization, J Mol Biol 384, 279-297.
75. Wang, X., Vitalis, A., Wyczalkowski, M. A., and Pappu, R. V. (2006) Characterizing the conformational ensemble of monomeric polyglutamine, Proteins 63, 297-311.
76. Williamson, T. E., Vitalis, A., Crick, S. L., and Pappu, R. V. (2010) Modulation of polyglutamine conformations and dimer formation by the N - terminus of huntingtin, J Mol Biol 396, 1295-1309.
77. Tran, H. T., Mao, A., and Pappu, R. V. (2008) Role of backbone-solvent interactions in determining conformational equilibria of intrinsically disordered proteins, J Am Chem Soc 130, 7380-7392.
78. Uversky, V. N. (2009) Intrinsically disordered proteins and their environment: Effects of strong denaturants, temperature, pH, counter ions, membranes, binding partners, osmolytes, and macromolecular crowding, Protein J 28, 305-325.
79. Ptitsyn, O. B. and Uversky, V. N. (1994) The molten globule is a third thermodynamical state of protein molecules, FEBS Lett 341, 15-18.
80. Uversky, V. N. and Ptitsyn, O. B. (1996) All- or - none solvent- induced transitions between native, molten globule and unfolded states in globular proteins, Fold Des 1, 117-122.
81. Neyroz, P., Zambelli, B., and Ciurli, S. (2006) Intrinsically disordered structure of Bacillus pasteurii UreG as revealed by steady - state and time - resolved fluorescence spectroscopy, Biochemistry 45, 8918-8930.
82. Permyakov, S. E., Millett, I. S., Doniach, S., Permyakov, E. A., and Uversky, V. N. (2003) Natively unfolded C - terminal domain of caldesmon remains substantially unstructured after the effective binding to calmodulin, Proteins 53, 855-862.
83. Uversky, V. N., Permyakov, S. E., Zagranichny, V. E., Rodionov, I. L., Fink, A. L., Cherskaya, A. M., Wasserman, L. A., and Permyakov, E. A. (2002) Effect of zinc and temperature on the conformation of the gamma subunit of retinal phosphodiesterase: A natively unfolded protein, J Proteome Res 1, 149-159.
84. Uversky, V. N., Gillespie, J. R., Millett, I. S., Khodyakova, A. V., Vasiliev, A. M., Chernovskaya, T. V., Vasilenko, R. N., Kozlovskaya, G. D., Dolgikh, D. A., Fink, A. L., Doniach, S., and Abramov, V. M. (1999) Natively unfolded human prothymosin alpha adopts partially folded collapsed conformation at acidic pH, Biochemistry 38, 15009-15016.
85. Konno, T., Tanaka, N., Kataoka, M., Takano, E., and Maki, M. (1997) A circular dichroism study of preferential hydration and alcohol effects on a denatured protein, pig calpastatin domain I, Biochim Biophys Acta 1342, 73-82.
86. Lynn, A., Chandra, S., Malhotra, P., and Chauhan, V. S. (1999) Heme binding and polymerization by Plasmodium falciparum histidine rich protein II: Influence of pH on activity and conformation, FEBS Lett 459, 267-271.
87. Johansson, J., Gudmundsson, G. H., Rottenberg, M. E., Berndt, K. D., and Agerberth, B. (1998) Conformation - dependent antibacterial activity of the naturally occurring human peptide LL - 37, J Biol Chem 273, 3718-3724.
88. Uversky, V. N. (2011) Multitude of binding modes attainable by intrinsically disordered proteins: A portrait gallery of disorder - based complexes, Chem Soc Rev 40, 1623-1634.
89. Mohan, A. (2006) MoRFs: A dataset of molecular recognition features. Master ' s thesis, Indiana University, School of Informatics, p. 59.
90. Oldfield, C. J., Cheng, Y., Cortese, M. S., Romero, P., Uversky, V. N., and Dunker, A. K. (2005) Coupled folding and binding with alpha - helix - forming molecular recognition elements, Biochemistry 44, 12454-12470.
91. Vacic, V., Oldfield, C. J., Mohan, A., Radivojac, P., Cortese, M. S., Uversky, V. N., and Dunker, A. K. (2007) Characterization of molecular recognition features, MoRFs, and their binding partners, J Proteome Res 6, 2351-2366.
92. Galea, C. A., Nourse, A., Wang, Y., Sivakolundu, S. G., Heller, W. T., and Kriwacki, R. W. (2008) Role of intrinsic flexibility in signal transduction mediated by the cell cycle regulator, p27 Kip1, J Mol Biol 376, 827-838.
93. Galea, C. A., Wang, Y., Sivakolundu, S. G., and Kriwacki, R. W. (2008) Regulation of cell division by intrinsically unstructured proteins: Intrinsic flexibility, modularity, and signaling conduits, Biochemistry 47, 7598-7609.
94. Graham, T. A., Weaver, C., Mao, F., Kimelman, D., and Xu, W. (2000) Crystal structure of a beta - catenin/Tcf complex, Cell 103, 885-896.
95. Luscombe, N. M., Austin, S. E., Berman, H. M., and Thornton, J. M. (2000) An overview of the structures of protein - DNA complexes, Genome Biol 1, REVIEWS001.
96. Brodersen, D. E., Clemons, W. M., Jr, Carter, A. P., Wimberly, B. T., and Ramakrishnan, V. (2002) Crystal structure of the 30 S ribosomal subunit from Thermus thermophilus: Structure of the proteins and their interactions with 16 S RNA, J Mol Biol 316, 725-768.
97. Teschke, C. M. and King, J. (1992) Folding and assembly of oligomeric proteins in Escherichia coli, Curr Opin Biotechnol 3, 468-473.
98. Xu, D., Tsai, C. J., and Nussinov, R. (1998) Mechanism and evolution of protein dimerization, Protein Sci 7, 533-544.
99. Gunasekaran, K., Tsai, C. J., and Nussinov, R. (2004) Analysis of ordered and disordered protein complexes reveals structural features discriminating between stable and unstable monomers, J Mol Biol 341, 1327-1341.
100. Mason, J. M. and Arndt, K. M. (2004) Coiled coil domains: Stability, specificity, and biological implications, Chembiochem 5, 170-176.
101. Liu, J., Zheng, Q., Deng, Y., Cheng, C. S., Kallenbach, N. R., and Lu, M. (2006) A seven - helix coiled coil, Proc Natl Acad Sci U S A 103, 15457-15462.
102. Wolf, E., Kim, P. S., and Berger, B. (1997) MultiCoil: A program for predicting two -and three - stranded coiled coils, Protein Sci 6, 1179-1189.
103. Harbury, P. B., Plecs, J. J., Tidor, B., Alber, T., and Kim, P. S. (1998) High - resolution protein design with backbone freedom, Science 282, 1462-1467.
104. Stetefeld, J., Jenny, M., Schulthess, T., Landwehr, R., Engel, J., and Kammerer, R. A. (2000) Crystal structure of a naturally occurring parallel right - handed coiled coil tetramer, Nat Struct Biol 7, 772-776.
105. Ozbek, S., Engel, J., and Stetefeld, J. (2002) Storage function of cartilage oligomeric matrix protein: The crystal structure of the coiled - coil domain in complex with vitamin D(3), EMBO J 21, 5960-5968.
106. Low, H. H., Moncrieffe, M. C., and Lowe, J. (2004) The crystal structure of ZapA and its modulation of FtsZ polymerisation, J Mol Biol 341, 839-852.
107. Zhao, X., Ghaffari, S., Lodish, H., Malashkevich, V. N., and Kim, P. S. (2002) Structure of the Bcr - Abl oncoprotein oligomerization domain, Nat Struct Biol 9, 117-120.
108. Liu, X., Xu, L., Liu, Y., Tong, X., Zhu, G., Zhang, X. C., Li, X., and Rao, Z. (2009) Crystal structure of the hexamer of human heat shock factor binding protein 1, Proteins 75, 1-11.
109. Malashkevich, V. N., Schneider, B. J., McNally, M. L., Milhollen, M. A., Pang, J. X., and Kim, P. S. (1999) Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9 - A resolution, Proc Natl Acad Sci U S A 96, 2662-2667.
110. Malashkevich, V. N., Singh, M., and Kim, P. S. (2001) The trimer - of - hairpins motif in membrane fusion: Visna virus, Proc Natl Acad Sci U S A 98, 8502-8506.
111. Glover, J. N. and Harrison, S. C. (1995) Crystal structure of the heterodimeric bZIP transcription factor c - Fos - c - Jun bound to DNA, Nature 373, 257-261.
112. Im, Y. J., Kang, G. B., Lee, J. H., Park, K. R., Song, H. E., Kim, E., Song, W. K., Park, D., and Eom, S. H. (2010) Structural basis for asymmetric association of the betaPIX coiled coil and shank PDZ, J Mol Biol 397, 457-466.
113. Siegert, R., Leroux, M. R., Scheufler, C., Hartl, F. U., and Moarefi, I. (2000) Structure of the molecular chaperone prefoldin: Unique interaction of multiple coiled coil tentacles with unfolded proteins, Cell 103, 621-632.
114. Lee, S., Sowa, M. E., Watanabe, Y. H., Sigler, P. B., Chiu, W., Yoshida, M., and Tsai, F. T. (2003) The structure of ClpB: A molecular chaperone that rescues proteins from an aggregated state, Cell 115, 229-240.
115. Oldfield, C. J., Meng, J., Yang, J. Y., Yang, M. Q., Uversky, V. N., and Dunker, A. K. (2008) Flexible nets: Disorder and induced fit in the associations of p53 and 14 - 3 - 3 with their partners, BMC Genomics 9, Suppl 1, S1.
116. Kajava, A. V., Baxa, U., and Steven, A. C. (2010) Beta arcades: Recurring motifs in naturally occurring and disease - related amyloid fibrils, FASEB J 24, 1311-1319.
117. Borg, M., Mittag, T., Pawson, T., Tyers, M., Forman - Kay, J. D., and Chan, H. S. (2007) Polyelectrostatic interactions of disordered ligands suggest a physical basis for ultrasensitivity, Proc Natl Acad Sci U S A 104, 9650-9655.
118. Mittag, T., Orlicky, S., Choy, W. Y., Tang, X., Lin, H., Sicheri, F., Kay, L. E., Tyers, M., and Forman - Kay, J. D. (2008) Dynamic equilibrium engagement of a polyvalent ligand with a single - site receptor, Proc Natl Acad Sci U S A 105, 17772-17777.
119. Mittag, T., Kay, L. E., and Forman - Kay, J. D. (2010) Protein dynamics and conformational disorder in molecular recognition, J Mol Recognit 23, 105-116.
120. Mittag, T., Marsh, J., Grishaev, A., Orlicky, S., Lin, H., Sicheri, F., Tyers, M., and Forman - Kay, J. D. (2010) Structure/function implications in a dynamic complex of the intrinsically disordered Sic1 with the Cdc4 subunit of an SCF ubiquitin ligase, Structure 18, 494-506.
121. Sigalov, A. B., Kim, W. M., Saline, M., and Stern, L. J. (2008) The intrinsically disordered cytoplasmic domain of the T cell receptor zeta chain binds to the nef protein of simian immunodeficiency virus without a disorder - to - order transition, Biochemistry 47, 12942-12944.
122. Sigalov, A., Aivazian, D., and Stern, L. (2004) Homooligomerization of the cytoplasmic domain of the T cell receptor zeta chain and of other proteins containing the immunoreceptor tyrosine - based activation motif, Biochemistry 43, 2049-2061.
123. Sigalov, A. B., Zhuravleva, A. V., and Orekhov, V. Y. (2007) Binding of intrinsically disordered proteins is not necessarily accompanied by a structural transition to a folded form, B iochimie 89, 419-421.
124. Pometun, M. S., Chekmenev, E. Y., and Wittebort, R. J. (2004) Quantitative observation of backbone disorder in native elastin, J Biol Chem 279, 7982-7987.
125. Sigalov, A. B. and Hendricks, G. M. (2009) Membrane binding mode of intrinsically disordered cytoplasmic domains of T cell receptor signaling subunits depends on lipid composition, B iochem Biophys Res Commun 3 89, 388-393.
126. Sigalov, A. B., Aivazian, D. A., Uversky, V. N., and Stern, L. J. (2006) Lipid - binding activity of intrinsically unstructured cytoplasmic domains of multichain immune recognition receptor signaling subunits, Biochemistry 45, 15731-15739.
127. Tompa, P. and Fuxreiter, M. (2008) Fuzzy complexes: Polymorphism and structural disorder in protein-protein interactions, Trends Biochem Sci 33, 2-8.
128. Hazy, E. and Tompa, P. (2009) Limitations of induced folding in molecular recognition by intrinsically disordered proteins, Chemphyschem 10, 1415-1419.
129. Liu, Y., Fratini, E., Baglioni, P., Chen, W. R., and Chen, S. H. (2005) Effective long -range attraction between protein molecules in solutions studied by small angle neutron scattering, Phys Rev Lett 95, 118102.
130. Schulz, G. E. (1979) Nucleotide binding proteins. In: Balaban, M. (ed.), Molecular mechanism of biological recognition. Elsevier/North - Holland Biomedical Press, New York, pp. 79-94.
131. Pontius, B. W. (1993) Close encounters: Why unstructured, polymeric domains can increase rates of specific macromolecular association, Trends Biochem Sci 18, 181-186.
132. Dunker, A. K., Brown, C. J., Lawson, J. D., Iakoucheva, L. M., and Obradovic, Z. (2002) Intrinsic disorder and protein function, Biochemistry 41, 6573-6582.
133. Dunker, A. K., Brown, C. J., and Obradovic, Z. (2002) Identification and functions of usefully disordered proteins, Adv Protein Chem 62, 25-49.
134. Dyson, H. J. and Wright, P. E. (2002) Coupling of folding and binding for unstructured proteins, Curr Opin Struct Biol 12, 54-60.
135. Dyson, H. J. and Wright, P. E. (2005) Intrinsically unstructured proteins and their functions, N at Rev Mol Cell Biol 6, 197-208.
136. Plaxco, K. W. and Gross, M. (1997) Cell biology. The importance of being unfolded, Nature 386, 657, 659.
137. Spolar, R. S. and Record, M. T., Jr (1994) Coupling of local folding to site - specific binding of proteins to DNA, Science 263, 777-784.
138. Karush, F. (1950) Heterogeneity of the binding sites of bovine serum albumin, J Am Chem Soc 72, 2705-2713.
139. Kriwacki, R. W., Hengst, L., Tennant, L., Reed, S. I., and Wright, P. E. (1996) Structural studies of p21 Waf1/Cip1/Sdi1 in the free and Cdk2 - bound state: Conformational disorder mediates binding diversity, Proc Natl Acad Sci U S A 93, 11504-11509.
140. Dunker, A. K., Obradovic, Z., Romero, P., Kissinger, C., and Villafranca, E. (1997) On the importance of being disordered, PDB Newsletter 81, 3-5.
141. Romero, P., Obradovic, Z., Li, X., Garner, E. C., Brown, C. J., and Dunker, A. K. (2001) Sequence complexity of disordered protein, Protein Struct Funct Genet 42, 38-49.
142. Brown, C. J., Takayama, S., Campen, A. M., Vise, P., Marshall, T. W., Oldfield, C. J., Williams, C. J., and Dunker, A. K. (2002) Evolutionary rate heterogeneity in proteins with long disordered regions, J Mol Evol 55, 104-110.
143. Cortese, M. S., Uversky, V. N., and Dunker, A. K. (2008) Intrinsic disorder in scaffold proteins: Getting more from less, Prog Biophys Mol Biol 98, 85-106.
144. Tompa, P. and Csermely, P. (2004) The role of structural disorder in the function of RNA and protein chaperones, FASEB J 18, 1169-1175.
145. Xie, H., Vucetic, S., Iakoucheva, L. M., Oldfield, C. J., Dunker, A. K., Uversky, V. N., and Obradovic, Z. (2007) Functional anthology of intrinsic disorder. 1. Biological processes and functions of proteins with long disordered regions, J Proteome Res 6, 1882-1898.
146. Vucetic, S., Xie, H., Iakoucheva, L. M., Oldfield, C. J., Dunker, A. K., Obradovic, Z., and Uversky, V. N. (2007) Functional anthology of intrinsic disorder. 2. Cellular components, domains, technical terms, developmental processes, and coding sequence diversities correlated with long disordered regions, J Proteome Res 6, 1899-1916.
147. Xie, H., Vucetic, S., Iakoucheva, L. M., Oldfield, C. J., Dunker, A. K., Obradovic, Z., and Uversky, V. N. (2007) Functional anthology of intrinsic disorder. 3. Ligands, post -translational modifications, and diseases associated with intrinsically disordered proteins, J Proteome Res 6, 1917-1932.
148. Marks, F. (1996) Protein phosphorylation, Wiley, VCH Weinheim, New York, Basel, Cambridge, Tokyo.
149. Johnson, L. N. and Lewis, R. J. (2001) Structural basis for control by phosphorylation, Chem Rev 101, 2209-2242.
150. Iakoucheva, L. M., Radivojac, P., Brown, C. J., O ' Connor, T. R., Sikes, J. G., Obradovic, Z., and Dunker, A. K. (2004) The importance of intrinsic disorder for protein phosphorylation, N ucleic Acids Res 32, 1037-1049.
151. Bossemeyer, D., Engh, R. A., Kinzel, V., Ponstingl, H., and Huber, R. (1993) Phosphotransferase and substrate binding mechanism of the cAMP - dependent protein kinase catalytic subunit from porcine heart as deduced from the 2.0 A structure of the complex with Mn2 + adenylyl imidodiphosphate and inhibitor peptide PKI(5 - 24), EMBO J 12, 849-859.
152. Narayana, N., Cox, S., Shaltiel, S., Taylor, S. S., and Xuong, N. (1997) Crystal structure of a polyhistidine - tagged recombinant catalytic subunit of cAMP - dependent protein kinase complexed with the peptide inhibitor PKI(5 - 24) and adenosine, Biochemistry 36, 4438-4448.
153. Lowe, E. D., Noble, M. E., Skamnaki, V. T., Oikonomakos, N. G., Owen, D. J., and Johnson, L. N. (1997) The crystal structure of a phosphorylase kinase peptide substrate complex: Kinase substrate recognition, Embo J 16, 6646-6658.
154. ter Haar, E., Coll, J. T., Austen, D. A., Hsiao, H. M., Swenson, L., and Jain, J. (2001) Structure of GSK3beta reveals a primed phosphorylation mechanism, Nat Struct Biol 8, 593-596.
155. Hubbard, S. R. (1997) Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog, Embo J 16, 5572-5581.
156. McDonald, I. K. and Thornton, J. M. (1994) Satisfying hydrogen bonding potential in proteins, J Mol Biol 238, 777-793.
157. Radivojac, P., Vacic, V., Haynes, C., Cocklin, R. R., Mohan, A., Heyen, J. W., Goebl, M. G., and Iakoucheva, L. M. (2010) Identification, analysis, and prediction of protein ubiquitination sites, Proteins 78, 365-380.
158. Sambrook, J. (1977) Adenovirus amazes at Cold Spring Harbor, Nature 268, 101-104.
159. Black, D. L. (2003) Mechanisms of alternative pre - messenger RNA splicing, Annu Rev Biochem 72, 291-336.
160. Gilbert, W. (1978) Why genes in pieces? Nature 271, 501.
161. Ast, G. (2004) How did alternative splicing evolve? Nat Rev Genet 5, 773-782.
162. Stamm, S., Ben - Ari, S., Rafalska, I., Tang, Y., Zhang, Z., Toiber, D., Thanaraj, T. A., and Soreq, H. (2005) Function of alternative splicing, Gene 344, 1-20.
163. Brett, D., Hanke, J., Lehmann, G., Haase, S., Delbruck, S., Krueger, S., Reich, J., and Bork, P. (2000) EST comparison indicates 38% of human mRNAs contain possible alternative splice forms, FEBS Lett 474, 83-86.
164. Johnson, J. M., Castle, J., Garrett - Engele, P., Kan, Z., Loerch, P. M., Armour, C. D., Santos, R., Schadt, E. E., Stoughton, R., and Shoemaker, D. D. (2003) Genome - wide survey of human alternative pre - mRNA splicing with exon junction microarrays, Science 302, 2141-2144.
165. Graveley, B. R. (2001) Alternative splicing: Increasing diversity in the proteomic world, Trends Genet 17, 100-107.
166. Minneman, K. P. (2001) Splice variants of G protein - coupled receptors, Mol Interv 1, 108-116.
167. Thai, T. H. and Kearney, J. F. (2004) Distinct and opposite activities of human terminal deoxynucleotidyltransferase splice variants, J Immunol 173, 4009-4019.
168. Scheper, W., Zwart, R., and Baas, F. (2004) Alternative splicing in the N - terminus of Alzheimer ' s presenilin 1, Neurogenetics 5, 223-227.
169. Roberts, R., Timchenko, N. A., Miller, J. W., Reddy, S., Caskey, C. T., Swanson, M. S., and Timchenko, L. T. (1997) Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA - binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice, Proc Natl Acad Sci U S A 94, 13221-13226.
170. Ma, K., Inglis, J. D., Sharkey, A., Bickmore, W. A., Hill, R. E., Prosser, E. J., Speed, R. M., Thomson, E. J., Jobling, M., Taylor, K., et al. (1993) A Y chromosome gene family with RNA - binding protein homology: Candidates for the azoospermia factor AZF controlling human spermatogenesis, Cell 75, 1287-1295.
171. Lovestone, S., Reynolds, C. H., Latimer, D., Davis, D. R., Anderton, B. H., Gallo, J. M., Hanger, D., Mulot, S., Marquardt, B., Stabel, S., et al. (1994) Alzheimer ' s disease -like phosphorylation of the microtubule - associated protein tau by glycogen synthase kinase - 3 in transfected mammalian cells, Curr Biol 4, 1077-1086.
172. Beyer, K., Domingo - Sabat, M., Humbert, J., Carrato, C., Ferrer, I., and Ariza, A. (2008) Differential expression of alpha - synuclein, parkin, and synphilin - 1 isoforms in Lewy body disease, Neurogenetics 9, 163-172.
173. Beyer, K., Domingo - Sabat, M., Lao, J. I., Carrato, C., Ferrer, I., and Ariza, A. (2008) Identification and characterization of a new alpha - synuclein isoform and its role in Lewy body diseases, Neurogenetics 9, 15-23.
174. Venables, J. P. (2004) Aberrant and alternative splicing in cancer, Cancer Res 64, 7647-7654.
175. Wang, P., Yan, B., Guo, J. T., Hicks, C., and Xu, Y. (2005) Structural genomics analysis of alternative splicing and application to isoform structure modeling, Proc Natl Acad Sci U S A 102, 18920-18925.
176. Furnham, N., Ruffle, S., and Southan, C. (2004) Splice variants: A homology modeling approach, P roteins 54, 596-608.
177. Romero, P. R., Zaidi, S., Fang, Y. Y., Uversky, V. N., Radivojac, P., Oldfield, C. J., Cortese, M. S., Sickmeier, M., LeGall, T., Obradovic, Z., and Dunker, A. K. (2006) Alternative splicing in concert with protein intrinsic disorder enables increased functional diversity in multicellular organisms, Proc Natl Acad Sci U S A 103, 8390-8395.
178. Dunker, A. K. and Uversky, V. N. (2008) Signal transduction via unstructured protein conduits, N at Chem Biol 4, 229-230.
179. Dunker, A. K., Silman, I., Uversky, V. N., and Sussman, J. L. (2008) Function and structure of inherently disordered proteins, Curr Opin Struct Biol 18, 756-764.
180. Dosztanyi, Z., Csizmok, V., Tompa, P., and Simon, I. (2005) IUPred: Web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content, Bioinformatics 21, 3433-3434.
181. Uversky, V. N. and Dunker, A. K. (2008) Biochemistry. Controlled chaos, Science 322, 1340-1341.
182. Gsponer, J., Futschik, M. E., Teichmann, S. A., and Babu, M. M. (2008) Tight regulation of unstructured proteins: From transcript synthesis to protein degradation, Science 322, 1365-1368.
183. Ward, J. J., Sodhi, J. S., McGuffin, L. J., Buxton, B. F., and Jones, D. T. (2004) Prediction and functional analysis of native disorder in proteins from the three kingdoms of life, J Mol Biol 337, 635-645.
184. Grimmler, M., Wang, Y., Mund, T., Cilensek, Z., Keidel, E. M., Waddell, M. B., Jakel, H., Kullmann, M., Kriwacki, R. W., and Hengst, L. (2007) Cdk - inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases, Cell 128, 269-280.
185. Tompa, P. (2005) The interplay between structure and function in intrinsically unstructured proteins, FEBS Lett 579, 3346-3354.
186. Paliy, O., Gargac, S. M., Cheng, Y., Uversky, V. N., and Dunker, A. K. (2008) Protein disorder is positively correlated with gene expression in Escherichia coli, J Proteome Res 7, 2234-2245.
187. Fernandez, A. and Scheraga, H. A. (2003) Insufficiently dehydrated hydrogen bonds as determinants of protein interactions, Proc Natl Acad Sci U S A 100, 113-118.
188. Fernandez, A. (2004) Keeping dry and crossing membranes, Nat Biotechnol 22, 1081-1084.
189. Kelly, J. W. (1998) The alternative conformations of amyloidogenic proteins and their multi - step assembly pathways, Curr Opin Struct Biol 8, 101-106.
190. Dobson, C. M. (1999) Protein misfolding, evolution and disease, Trends Biochem Sci 24, 329-332.
191. Bellotti, V., Mangione, P., and Stoppini, M. (1999) Biological activity and pathological implications of misfolded proteins, Cell Mol Life Sci 55, 977-991.
192. Uversky, V. N., Talapatra, A., Gillespie, J. R., and Fink, A. L. (1999) Protein deposits as the molecular basis of amyloidosis. I. Systemic amyloidoses, Med Sci Monit 5, 1001-1012.
193. Uversky, V. N., Talapatra, A., Gillespie, J. R., and Fink, A. L. (1999) Protein deposits as the molecular basis of amyloidosis. II. Localized amyloidosis and neurodegenerative disordres, M ed Sci Monit 5, 1238-1254.
194. Rochet, J. C. and Lansbury, P. T., Jr (2000) Amyloid fibrillogenesis: Themes and variations, C urr Opin Struct Biol 10, 60-68.
195. Uversky, V. N. and Fink, A. L. (2004) Conformational constraints for amyloid fibrillation: The importance of being unfolded, Biochim Biophys Acta 1698, 131-153.
196. Uversky, V. N. and Fink, A. L. (2005) Pathways to amyloid fibril formation: Partially folded intermediates in fibrillation of unfolded proteins. In: Sipe, J. D. (ed.), Amyloid proteins: The beta pleated sheet conformation and disease. Wiley - VCH, Verlag GmbH & Co. KGaA, Weinheim, Germany, pp. 247-265.
197. Glenner, G. G. and Wong, C. W. (1984) Alzheimer ' s disease and Down ' s syndrome: Sharing of a unique cerebrovascular amyloid fibril protein, Biochem Biophys Res Commun 122, 1131-1135.
198. Masters, C. L., Multhaup, G., Simms, G., Pottgiesser, J., Martins, R. N., and Beyreuther, K. (1985) Neuronal origin of a cerebral amyloid: Neurofibrillary tangles of Alzheimer ' s disease contain the same protein as the amyloid of plaque cores and blood vessels, Embo J 4, 2757-2763.
199. Lee, V. M., Balin, B. J., Otvos, L., Jr, and Trojanowski, J. Q. (1991) A68: A major subunit of paired helical filaments and derivatized forms of normal Tau, Science 251, 675-678.
200. Ueda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J., Ihara, Y., and Saitoh, T. (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease, Proc Natl Acad Sci U S A 90, 11282-11286.
201. Wisniewski, K. E., Dalton, A. J., McLachlan, C., Wen, G. Y., and Wisniewski, H. M. (1985) Alzheimer ' s disease in Down ' s syndrome: Clinicopathologic studies, Neurology 35, 957-961.
202. Dev, K. K., Hofele, K., Barbieri, S., Buchman, V. L., and van der Putten, H. (2003) Part II: Alpha - synuclein and its molecular pathophysiological role in neurodegenerative disease, N europharmacology 45, 14-44.
203. Prusiner, S. B. (2001) Shattuck lecture - Neurodegenerative diseases and prions, N Engl J Med 344, 1516-1526.
204. Zoghbi, H. Y. and Orr, H. T. (1999) Polyglutamine diseases: Protein cleavage and aggregation, C urr Opin Neurobiol 9, 566-570.
205. Okazawa, H. (2003) Polyglutamine diseases: A transcription disorder? Cell Mol Life Sci 60, 1427-1439.
206. Cummings, C. J. and Zoghbi, H. Y. (2000) Fourteen and counting: Unraveling trinucleotide repeat diseases, Hum Mol Genet 9, 909-916.
207. Gusella, J. F. and MacDonald, M. E. (2000) Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease, Nat Rev Neurosci 1, 109-115.
208. Orr, H. T. (2001) Beyond the Qs in the polyglutamine diseases, Genes Dev 15, 925-932.
209. Fischbeck, K. H. (2001) Polyglutamine expansion neurodegenerative disease, Brain Res Bull 56, 161-163.
210. Lee, H., Mok, K. H., Muhandiram, R., Park, K. H., Suk, J. E., Kim, D. H., Chang, J., Sung, Y. C., Choi, K. Y., and Han, K. H. (2000) Local structural elements in the mostly unstructured transcriptional activation domain of human p53, J Biol Chem 275, 29426-29432.
211. Adkins, J. N. and Lumb, K. J. (2002) Intrinsic structural disorder and sequence features of the cell cycle inhibitor p57Kip2, Proteins 46, 1-7.
212. Chang, B. S., Minn, A. J., Muchmore, S. W., Fesik, S. W., and Thompson, C. B. (1997) Identification of a novel regulatory domain in Bcl - X(L) and Bcl - 2, Embo J 16, 968-977.
213. Campbell, K. M., Terrell, A. R., Laybourn, P. J., and Lumb, K. J. (2000) Intrinsic structural disorder of the C - terminal activation domain from the bZIP transcription factor Fos, Biochemistry 39, 2708-2713.
214. Sunde, M., McGrath, K. C., Young, L., Matthews, J. M., Chua, E. L., Mackay, J. P., and Death, A. K. (2004) TC - 1 is a novel tumorigenic and natively disordered protein associated with thyroid cancer, Cancer Res 64, 2766-2773.
215. Uversky, V. N., Oldfield, C. J., and Dunker, A. K. (2008) Intrinsically disordered proteins in human diseases: Introducing the D2 concept, Annu Rev Biophys 37, 215-246.
216. Uversky, V. N., Oldfield, C. J., Midic, U., Xie, H., Xue, B., Vucetic, S., Iakoucheva, L. M., Obradovic, Z., and Dunker, A. K. (2009) Unfoldomics of human diseases: Linking protein intrinsic disorder with diseases, BMC Genomics 10, Suppl 1, S7.
217. Garner, E., Romero, P., Dunker, A. K., Brown, C., and Obradovic, Z. (1999) Predicting binding regions within disordered proteins, Genome Inform Ser Workshop Genome Inform 10, 41-50.
218. Cheng, Y., Oldfield, C. J., Meng, J., Romero, P., Uversky, V. N., and Dunker, A. K. (2007) Mining alpha - helix - forming molecular recognition features with cross species sequence alignments, Biochemistry 46, 13468-13477.
219. Chen, C. T., Wagner, H., and Still, W. C. (1998) Fluorescent, sequence - selective peptide detection by synthetic small molecules, Science 279, 851-853.
220. Chene, P. (2004) Inhibition of the p53 - hdm2 interaction with low molecular weight compounds, C ell Cycle 3, 460-461.
221. Chene, P. (2004) Inhibition of the p53 - MDM2 interaction: Targeting a protein-protein interface, Mol Cancer Res 2, 20-28.
222. Anderson, C. W. and Appella, E. (2004) Signaling to the p53 tumor suppressor through pathways activated by genotoxic and nongenotoxic stress. In: Bradshaw, R. A. and Dennis, E. A. (eds.), Handbook of cell signaling. Academic Press, New York, pp. 237-247.
223. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. (1991) p53 mutations in human cancers, Science 253, 49-53.
224. Balint, E. E. and Vousden, K. H. (2001) Activation and activities of the p53 tumour suppressor protein, Br J Cancer 85, 1813-1823.
225. Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., and Pavletich, N. P. (1996) Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain, Science 274, 948-953.
226. Bottger, A., Bottger, V., Sparks, A., Liu, W. L., Howard, S. F., and Lane, D. P. (1997) Design of a synthetic Mdm2 - binding mini protein that activates the p53 response in vivo, C urr Biol 7, 860-869.
227. Wasylyk, C., Salvi, R., Argentini, M., Dureuil, C., Delumeau, I., Abecassis, J., Debussche, L., and Wasylyk, B. (1999) p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53, Oncogene 18, 1921-1934.
228. Chene, P., Fuchs, J., Bohn, J., Garcia - Echeverria, C., Furet, P., and Fabbro, D. (2000) A small synthetic peptide, which inhibits the p53 - hdm2 interaction, stimulates the p53 pathway in tumour cell lines, J Mol Biol 299, 245-253.
229. Garcia - Echeverria, C., Chene, P., Blommers, M. J., and Furet, P. (2000) Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53, J Med Chem 43, 3205-3208.
230. Klein, C. and Vassilev, L. T. (2004) Targeting the p53 - MDM2 interaction to treat cancer, Br J Cancer 91, 1415-1419.
231. Vassilev, L. T. (2004) Small - molecule antagonists of p53 - MDM2 binding: Research tools and potential therapeutics, Cell Cycle 3, 419-421.
232. Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., Fotouhi, N., and Liu, E. A. (2004) In vivo activation of the p53 pathway by small - molecule antagonists of MDM2, Science 303, 844-848.
233. Cheng, Y., LeGall, T., Oldfield, C. J., Mueller, J. P., Van, Y. Y., Romero, P., Cortese, M. S., Uversky, V. N., and Dunker, A. K. (2006) Rational drug design via intrinsically disordered protein, Trends Biotechnol 24, 435-442.
234. Arkin, M. R. and Wells, J. A. (2004) Small - molecule inhibitors of protein-protein interactions: Progressing towards the dream, Nat Rev Drug Discov 3, 301-317.
235. Arkin, M. (2005) Protein-protein interactions and cancer: Small molecules going in for the kill, Curr Opin Chem Biol 9, 317-324.
236. Cochran, A. G. (2000) Antagonists of protein-protein interactions, Chem Biol 7, R85-R94.
237. Hammoudeh, D. I., Follis, A. V., Prochownik, E. V., and Metallo, S. J. (2009) Multiple independent binding sites for small - molecule inhibitors on the oncoprotein c - Myc, J Am Chem Soc 131, 7390-7401.